Osteopathic Medical Board Meeting

BOARD MEETING NOTICE AND AGENDA 
Date:   Thursday, January 17, 2019 
Time:   10:00 a.m. – 5:00 p.m. (or until the end of business)  
Location(s):  Department of Consumer Affairs   
Headquarters Building 2 (HQ2) 
1747 North Market Blvd.              
Hearing Room      
  Sacramento CA 95834    
  (916) 928-8390   
(Action may be taken on any items listed on the agenda and may be taken out of order, 
unless noticed for a certain time.) The Board plans to webcast this meeting on its 
website at https://thedcapage.wordpress.com/webcasts/ . Webcast availability cannot, 
however, be guaranteed due to limited resources or technical difficulties. The meeting 
will not be cancelled if webcast is not available. If you wish to participate or to have a 
guaranteed opportunity to observe, please plan to attend at a physical meeting location. 
Adjournment, if it is the only item that occurs after a closed session, may not be 
webcast. 
Open Session 
1. Call to Order and Roll Call / Establishment of a Quorum  
2. Public Comment for Items Not on the Agenda 
Note: The Board may not discuss or take action on any matter raised during this public comment 
section except to decide whether to place the matter on the agenda of a future meeting 
[Government Code Sections 11125, 11125.7(a)] 
3. Introduction of New Board Member(s) 
4. Election of Officers
5. President’s Report  
6. Review and Approval of Minutes: 
 September 27, 2018 Board Meeting 
 October 15, 2018 Teleconference 
 December 13, 2018 Board Meeting 
7.  Petition for Reinstatement of License, John Wogec, D.O., 20A 6934 
8. Petition for Early Termination of Probation, David Orringer, D.O., 20A 15139 
Pursuant to section 11126(c)(3) of the Government Code, the Board will meet in closed 
session for discussion and to take action on disciplinary matters, including the above 
petitions. 
RECONVENE IN OPEN SESSION 
9. DCA Update – Patrick Le, Assistant Deputy Director, DCA 
10.  Budget Update – Sarah Hinkle, DCA Budget Office 
11. Strategic Plan Update   
12. Review and Discussion - Medical Board of California Guidelines for the 
Recommendation of Cannabis for Medical Purposes   
13. Discussion of OMBC outreach and education efforts related to: 
 AB 1753 - Controlled Substance Prescription Form Serial Number 
Requirement 
 AB 2760 - Prescription drugs: prescribers: naloxone hydrochloride 
and other FDA-approved drugs 
14. Executive Director’s Report – Angie Burton 
 Licensing 
 Staffing  
 CURES 
 Enforcement Report / Discipline – Corey Sparks 
15. Introduction and Swearing in - New Executive Director   
16. Agenda Items for Next Meeting 
17. Future Meeting Dates 
For further information about this meeting, please contact Machiko Chong at  
916-928-7636 or in writing 1300 National Drive, Suite 150 Sacramento CA 95834. 
This notice can be accessed at www.ombc.ca.gov
Government Code section 11125.7 provides the opportunity for the public to address each 
agenda item during discussion or consideration by the Board prior to the Board taking any 
action on said item.  Members of the public will be provided appropriate opportunities to 
comment on any issue before the Board, but the Board President may, at his or her 
discretion, apportion available time among those who wish to speak.  Individuals may 
appear before the Board to discuss items not on the agenda; however, the Board can 
neither discuss nor take official action on these items at the time of the same meeting. 
(Gov. Code, sections 11125, 11125.7(a).) 
open to the public and all meeting locations are accessible to the physically disabled.  A 
person who needs a disability-related accommodation or modification in order to 
participate in the meeting, may make a request by contacting Machiko Chong, ADA 
Liaison, at (916) 928-7636 or via e-mail at Machiko.Chong@dca.ca.gov
 or may send a 
written request to the Board’s office at 1300 National Drive, Suite 150, Sacramento, CA 
95834-1991.  Providing your request at least five (5) bus